Effects of intragastric balloon in patients with nonalcoholic fatty liver disease and advanced fibrosis

Background and aims Effective therapy for clinically significant fibrosis in nonalcoholic fatty liver disease (NAFLD) is an unmet need. Data on the effectiveness of endoscopic placement of intragastric balloon (IGB) in patients with NAFLD are limited. In this study, we evaluated the impact of IGB pl...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Liver international 2021-09, Vol.41 (9), p.2112-2116
Hauptverfasser:	Salomone, Federico, Currenti, Walter, Magrì, Giovanni, Boškoski, Ivo, Zelber‐Sagi, Shira, Galvano, Fabio
Format:	Artikel
Sprache:	eng
Schlagworte:	Adverse events Attenuation Balloon treatment Body weight Body weight loss Clinical trials Endoscopy Fatty liver Fibrosis Gastroesophageal reflux Hemoglobin Hypertension intragastric balloon Liver Liver diseases liver stiffness NAFLD obesity Parameters Placement Reduction Signs and symptoms Stiffness Weight loss
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!